Identification of Biomarkers Including (18)FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Humbert Olivier; Riedinger Jean-Marc; Charon-Barra Celine; Berriolo-Riedinger Alina; Desmoulins Isabelle; Lorgis Veronique; Kanoun Salim; Coutant Charles; Fumoleau Pierre; Cochet Alexandre; Brunotte Francois

首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Identification of Biomarkers Including (18)FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

【24h】

Identification of Biomarkers Including (18)FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

机译：鉴定包括（18）FDG-PET / CT的生物标记物，用于早期预测三阴性乳腺癌对新辅助化疗的反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To investigate the value of the metabolic tumor response assessed with F-18-fluorodeoxyglucose positron emission tomography (FDG-PET), compared with clinicobiologic markers to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in women with triple-negative breast cancer (TNBC).

机译：目的：探讨F-18-氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）评估代谢性肿瘤反应的价值，并与临床生物学标志物进行比较，以预测三联症女性对新辅助化疗（NAC）的病理完全反应（pCR）。阴性乳腺癌（TNBC）。

著录项

来源
《Clinical cancer research: an official journal of the American Association for Cancer Research》 |2015年第24期|共9页
作者
Humbert Olivier; Riedinger Jean-Marc; Charon-Barra Celine; Berriolo-Riedinger Alina; Desmoulins Isabelle; Lorgis Veronique; Kanoun Salim; Coutant Charles; Fumoleau Pierre; Cochet Alexandre; Brunotte Francois;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Identification of Biomarkers Including (18)FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer [J] . Humbert Olivier, Riedinger Jean-Marc, Charon-Barra Celine, Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第24期

机译：鉴定包括（18）FDG-PET / CT的生物标记物，用于早期预测三阴性乳腺癌对新辅助化疗的反应
2. [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy [J] . Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, European Journal of Nuclear Medicine and Molecular Imaging . 2007,第12期

机译：[18 F] FDG-PET预测乳腺癌对新辅助化疗的完全病理反应
3. Prognostic impact of F-18-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer [J] . Groheux D., Giacchetti S., Delord M., European Journal of Nuclear Medicine and Molecular Imaging . 2015,第3期

机译：F-18-FDG PET / CT分期对三阴性乳腺癌预后的影响以及对新辅助化疗的病理反应
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Breast Cancer Spatial Heterogeneity in Near-Infrared Spectra and the Prediction of Neoadjuvant Chemotherapy Response [D] . Santoro, Ylenia 2012

机译：乳腺癌在近红外光谱中的空间异质性及新辅助化疗反应的预测
6. Early Prediction of Tumor Response to Neoadjuvant Chemotherapy and Clinical Outcome in Breast Cancer Using a Novel FDG-PET Parameter for Cancer Stem Cell Metabolism [O] . Chanwoo Kim, Sang-Ah Han, Kyu Yeoun Won, 2020

机译：利用新型FDG-PET参数对乳腺癌新辅助化疗和癌症干细胞代谢的新乳腺癌肿瘤反应及临床结果的早期预测
7. Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer [O] . Yiqun Han, Jiayu Wang, Binghe Xu 2020

机译：新型生物标志物和预测模型对新型乳腺癌新辅助治疗的病理完全反应

Identification of Biomarkers Including (18)FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅